 | • レポートコード：QYR2104Z4439 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、パーキンソン病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品治療、医療機器治療）、用途別市場規模（40歳以下、40〜65歳、65歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・パーキンソン病治療薬の市場動向 ・企業の競争状況、市場シェア ・パーキンソン病治療薬の種類別市場規模（医薬品治療、医療機器治療） ・パーキンソン病治療薬の用途別市場規模（40歳以下、40〜65歳、65歳以上） ・パーキンソン病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・パーキンソン病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・パーキンソン病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パーキンソン病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・パーキンソン病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Novartis、Boehringer Ingelheim、Teva Pharmaceutical、Abbvie、Merck、Akorn、Kyowa Hakko Kirin Pharma、Astellas Pharma、Desitin Arzneimittel、Endo Pharmaceuticals、F.Hoffmann-La Roche、H.Lundbeck、Valeant、Apokyn、Orion、Stada Arzneimittel、US WorldMeds、Bausch Health） ・結論 |
Market Analysis and Insights: Global Parkinson’s Disease Therapeutics Market
The global Parkinson’s Disease Therapeutics market size is projected to reach US$ 3533.7 million by 2026, from US$ 2337.8 million in 2019, at a CAGR of 6.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson’s Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson’s Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson’s Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson’s Disease Therapeutics market.
Global Parkinson’s Disease Therapeutics Scope and Market Size
Parkinson’s Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medications Therapeutics
Medical Devices Therapeutics
Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Merck
Akorn
Kyowa Hakko Kirin Pharma
Astellas Pharma
Teva Pharmaceutical
Abbvie
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications Therapeutics
1.2.3 Medical Devices Therapeutics
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2016-2027)
2.2 Parkinson’s Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson’s Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson’s Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson’s Disease Therapeutics Industry Dynamic
2.3.1 Parkinson’s Disease Therapeutics Market Trends
2.3.2 Parkinson’s Disease Therapeutics Market Drivers
2.3.3 Parkinson’s Disease Therapeutics Market Challenges
2.3.4 Parkinson’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Therapeutics Revenue
3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2020
3.5 Parkinson’s Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2022-2027)
5 Parkinson’s Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parkinson’s Disease Therapeutics Market Size (2016-2027)
6.2 North America Parkinson’s Disease Therapeutics Market Size by Type
6.2.1 North America Parkinson’s Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Parkinson’s Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Parkinson’s Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Parkinson’s Disease Therapeutics Market Size by Application
6.3.1 North America Parkinson’s Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Parkinson’s Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Parkinson’s Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Parkinson’s Disease Therapeutics Market Size by Country
6.4.1 North America Parkinson’s Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Parkinson’s Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Parkinson’s Disease Therapeutics Market Size (2016-2027)
7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson’s Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Parkinson’s Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson’s Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Parkinson’s Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Parkinson’s Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country
7.4.1 Europe Parkinson’s Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Parkinson’s Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson’s Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Parkinson’s Disease Therapeutics Market Size by Type
9.2.1 Latin America Parkinson’s Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson’s Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson’s Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Parkinson’s Disease Therapeutics Market Size by Application
9.3.1 Latin America Parkinson’s Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson’s Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson’s Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Parkinson’s Disease Therapeutics Market Size by Country
9.4.1 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson’s Disease Therapeutics Introduction
11.1.4 GSK Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson’s Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Parkinson’s Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.4.4 Teva Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Parkinson’s Disease Therapeutics Introduction
11.5.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.5.5 Abbvie Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Parkinson’s Disease Therapeutics Introduction
11.6.4 Merck Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Parkinson’s Disease Therapeutics Introduction
11.7.4 Akorn Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.7.5 Akorn Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson’s Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson’s Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson’s Disease Therapeutics Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson’s Disease Therapeutics Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson’s Disease Therapeutics Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson’s Disease Therapeutics Introduction
11.13.4 H.Lundbeck Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson’s Disease Therapeutics Introduction
11.14.4 Valeant Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson’s Disease Therapeutics Introduction
11.15.4 Apokyn Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson’s Disease Therapeutics Introduction
11.16.4 Orion Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson’s Disease Therapeutics Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson’s Disease Therapeutics Introduction
11.18.4 US WorldMeds Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
11.18.5 US WorldMeds Recent Development
11.18 Bausch Health
.1 Bausch Health Company Details
.2 Bausch Health Business Overview
.3 Bausch Health Parkinson’s Disease Therapeutics Introduction
.4 Bausch Health Revenue in Parkinson’s Disease Therapeutics Business (2016-2021)
.5 Bausch Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications Therapeutics
Table 3. Key Players of Medical Devices Therapeutics
Table 4. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Parkinson's Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Parkinson's Disease Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Table 10. Parkinson's Disease Therapeutics Market Trends
Table 11. Parkinson's Disease Therapeutics Market Drivers
Table 12. Parkinson's Disease Therapeutics Market Challenges
Table 13. Parkinson's Disease Therapeutics Market Restraints
Table 14. Global Parkinson's Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Parkinson's Disease Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020)
Table 17. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 21. Date of Enter into Parkinson's Disease Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. GSK Company Details
Table 62. GSK Business Overview
Table 63. GSK Parkinson's Disease Therapeutics Product
Table 64. GSK Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 65. GSK Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Parkinson's Disease Therapeutics Product
Table 69. Novartis Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 74. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Teva Pharmaceutical Company Details
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 79. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Parkinson's Disease Therapeutics Product
Table 84. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Abbvie Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Parkinson's Disease Therapeutics Product
Table 89. Merck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Akorn Company Details
Table 92. Akorn Business Overview
Table 93. Akorn Parkinson's Disease Therapeutics Product
Table 94. Akorn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Akorn Recent Development
Table 96. Kyowa Hakko Kirin Pharma Company Details
Table 97. Kyowa Hakko Kirin Pharma Business Overview
Table 98. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Kyowa Hakko Kirin Pharma Recent Development
Table 100. Astellas Pharma Company Details
Table 101. Astellas Pharma Business Overview
Table 102. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 103. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Astellas Pharma Recent Development
Table 105. Desitin Arzneimittel Company Details
Table 106. Desitin Arzneimittel Business Overview
Table 107. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 108. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Desitin Arzneimittel Recent Development
Table 110. Endo Pharmaceuticals Company Details
Table 111. Endo Pharmaceuticals Business Overview
Table 112. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 113. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Endo Pharmaceuticals Recent Development
Table 115. F.Hoffmann-La Roche Company Details
Table 116. F.Hoffmann-La Roche Business Overview
Table 117. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Product
Table 118. F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 119. F.Hoffmann-La Roche Recent Development
Table 120. H.Lundbeck Company Details
Table 121. H.Lundbeck Business Overview
Table 122. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 123. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 124. H.Lundbeck Recent Development
Table 125. Valeant Company Details
Table 126. Valeant Business Overview
Table 127. Valeant Parkinson's Disease Therapeutics Product
Table 128. Valeant Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Valeant Recent Development
Table 130. Apokyn Company Details
Table 131. Apokyn Business Overview
Table 132. Apokyn Parkinson's Disease Therapeutics Product
Table 133. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Apokyn Recent Development
Table 135. Orion Company Details
Table 136. Orion Business Overview
Table 137. Orion Parkinson's Disease Therapeutics Product
Table 138. Orion Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Orion Recent Development
Table 140. Stada Arzneimittel Company Details
Table 141. Stada Arzneimittel Business Overview
Table 142. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 143. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Stada Arzneimittel Recent Development
Table 145. US WorldMeds Company Details
Table 146. US WorldMeds Business Overview
Table 147. US WorldMeds Parkinson's Disease Therapeutics Product
Table 148. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 149. US WorldMeds Recent Development
Table 150. Bausch Health Company Details
Table 151. Bausch Health Business Overview
Table 152. Bausch Health Parkinson's Disease Therapeutics Product
Table 153. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 154. Bausch Health Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medications Therapeutics Features
Figure 3. Medical Devices Therapeutics Features
Figure 4. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Under 40 Years Old Case Studies
Figure 6. 40-65 Years Old Case Studies
Figure 7. Above 65 Years Old Case Studies
Figure 8. Parkinson's Disease Therapeutics Report Years Considered
Figure 9. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Parkinson's Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Parkinson's Disease Therapeutics Market Share by Players in 2020
Figure 14. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2020
Figure 16. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2016-2027)
Figure 38. China Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 61. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 63. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 64. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 65. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 68. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 69. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 70. Valeant Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 71. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 72. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 73. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 74. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 75. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のパーキンソン病治療薬市場規模・現状・予測（2021年-2027年） Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. Market Analysis and Insights: Global Parkinson’s Disease Therapeutics Market The global Parkinson’s Disease Therapeutics market size is projected to reach US$ 3533.7 million by 2026, from …- 世界のパーキンソン病治療薬市場 2021：企業別、地域別、種類・用途別 The Parkinson’s Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の非アルコール性脂肪肝疾患治療薬市場規模・現状・予測（2021年-2027年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …